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Background: While Italy has implemented some tobacco control policies over the last few decades, which resulted
in a decreased smoking prevalence, there is still considerable scope to strengthen tobacco control policies
consistent with the World Health Organization (WHO) policy guidelines. The present study aims to evaluate the
effect of past and project the effect of future tobacco control policies on smoking prevalence and associated
premature mortality in Italy.
Methods: To assess, individually and in combination, the effect of seven types of policies, we used the SimSmoke
simulation model of tobacco control policy. The model uses population, smoking rates and tobacco control policy
data for Italy.
Results: Significant reductions of smoking prevalence and premature mortality can be achieved through tobacco
price increases, high intensity media campaigns, comprehensive cessation treatment program, strong health
warnings, stricter smoke-free air regulations and advertising bans, and youth access laws. With a comprehensive
approach, the smoking prevalence can be decreased by as much as 12% soon after the policies are in place,
increasing to a 30% reduction in the next twenty years and a 34% reduction by 30 years in 2040. Without effective
tobacco control policies, a total of almost 300 thousand lives will be prematurely lost due to smoking by the year
2040.
Conclusion: Besides presenting the benefits of a comprehensive tobacco control strategy, the model helps identify
information gaps in surveillance and evaluation schemes that will promote the effectiveness of future tobacco
control policy in Italy.
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The Framework Convention on Tobacco Control
(FCTC), the first treaty negotiated under the auspices of
the World Health Organization (WHO), was developed
in response to the globalization of the tobacco epidemic.
The FCTC suggestions have been formalized in the
WHO MPOWER package. In defining a set of policies,
WHO suggests that each nation impose taxes on cigar-
ettes that constitute at least 75% of the retail price,* Correspondence: silvano.gallus@marionegri.it
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reproduction in any medium, provided the orrequire large, bold and graphic health warnings, provide
broad access to cessation treatments, conduct a well-
funded mass-media campaign, and implement and en-
force comprehensive smoke-free indoor air laws and ad-
vertising/marketing restrictions [1,2].
These recommendations are the result of a large and
growing number of scientific studies conducted over the
last five decades, showing the effectiveness of the above
mentioned strategies to control tobacco. Substantial evi-
dence indicates that higher cigarette taxes, clean air
laws, advertising bans, and media campaigns can appre-
ciably reduce adult smoking rates, especially when com-
bined as a comprehensive strategy [3-6]. Evidence is
mounting for health warnings and cessation treatmentd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ation, but also lead current smokers to quit. Quitting
can halt or even reverse many of the health problems
associated with smoking [7,8]. Therefore, smoking rates,
and consequently smoking attributable deaths (SAD),
are reduced in response to changes in tobacco control
policies.
Various countries stand in different stages of the
tobacco epidemic [9] and have already introduced differ-
ent more or less comprehensive and observed strategies
to control tobacco [10]. Thus, each country has different
benefits in introducing a new policy or in extending an
already implemented anti-tobacco regulation. It is there-
fore important to analyze and quantify the effects of
introducing new policies on smoking rates in each coun-
try. Since the ability of purely statistical studies to
analyze the issue is limited, simulation models provide a
useful tool in combining information from different
sources to examine how the effects of public policies un-
fold over time in complex social systems [11,12]. One of
these simulation models, the SimSmoke model, which
has been validated in several countries [13,14] and states
[13,15,16], simultaneously considers a broad array of
public policies [17].
This study uses a modified version of the SimSmoke
tobacco control policy simulation model (Italy SimSmoke)
to examine the effect that the introduction of tobacco
control policies might have on smoking rates and
deaths due to smoking in Italy, which ratified the FCTC
in July 2008. Italy SimSmoke assesses the effect of
tobacco control policies, including price increases on
cigarettes, smoke-free air laws, media campaigns, adver-
tising bans, health warnings, cessation treatment pol-
icies, and youth access enforcement, on smoking rates
and SADs, overall and by age and gender.
Methods
SimSmoke includes a population model, a smoking
model, a SAD model, and policy modules [12,18,19].
The simulation model begins in a baseline year with the
population divided into smokers, never smokers, and
former smokers by age and gender. The baseline year is
1999 based on the availability of a large scale study for
that year and stability of policies during that period.
A discrete time, first-order Markov process is
employed to project future population growth through
fertility and deaths, and smoking rates through smoking
initiation, cessation, and relapse. The data used in Italy
SimSmoke are summarized in Table 1.
Population model
The population evolves over time due to deaths and
births. Sex and age-specific population data for the year
1999 were available from the Italian Institute of Statistics(www.istat.it). Since the data were presented by age
group, the data were smoothed to obtain individual ages.
Mortality by age and gender and fertility rates by age
come from ISTAT for the year 2005. Projections from
the model keep population roughly constant, consistent
with data and projected population increases from
ISTAT.
Smoking model
Within the smoking model, individuals are classified as
never smokers from birth until they initiate smoking or
die. They may evolve from current to former smokers
through cessation or may return to current smokers
through relapse. The extent of relapse depends on the
number of years since quitting.
Smoking prevalence data for the period 1999–2009
were available from the Multipurpose Surveys “Aspects
of daily living”, carried out from 1993 onwards by the
Institute of Health Information and Statistics of Italy
(ISTAT) [20]. These surveys were carried out almost
every year on representative samples of the Italian popu-
lation (about 24,000 families and 54,000 persons distrib-
uted in about 850 Italian municipalities of different
population sizes). Smoking status was based on partici-
pant self-report as never, former, or current smoker [20].
Smoking prevalence and initiation rate data were linearly
interpolated to obtain data for the missing years. Figures
on the subdivision of former smokers by duration since
quitting were derived from the ISTAT Multipurpose Sur-
veys “Aspects of daily living” [20]. Because former-
smokers were not distinguished by years-quit data after
the first year, we used data from the Netherlands to esti-
mate the proportions in the years-quit categories of
1 year or more.
Due to empirical challenges in measuring initiation
and cessation and in order to ensure stability and in-
ternal consistency of the model, initiation rates at each
age were measured as the difference between the smok-
ing rate at that age year and the rate at the previous age
year. We examined data from ISTAT regarding when
smokers and former smokers stated that they first
started smoking. Based on that information, we allowed
initiation up through age 30.
To measure the annual cessation rate, we used data
available for those who quit in the last year. Using the
baseline smoking prevalence data, we constructed a ces-
sation rate by age and gender, measured as those who
quit in the last year as percent of “those currently smok-
ing plus those who quit in the last year”. Since that rate
does not allow for relapse of those who quit less than
one year ago, we applied a 50% relapse rate to that
measure. These rates are consistent with estimates sug-
gested by West [21,22] and those found in studies of
quitting behaviors in the Netherlands [23-25]. Since data
Table 1 Data used in Italy SimSmoke
Input Source Specifications
I. Population
A. Population Institute of Health Information
and Statistics of Italy (ISTAT)
Breakdowns by age and gender groups
B. Fertility rates ISTAT Breakdowns by age and gender groups
C. Mortality rates ISTAT Breakdowns by age and gender groups
II. Smoking and attributable deaths
A. Baseline smoking rates Multipurpose Surveys “Aspects of
daily living”, carried out from
1993 onwards by ISTAT
Breakdown of current, former and never
smokers by age and gender groups.
B. Initiation rates Change in smoking rates between
contiguous age groups
Breakdowns by age and gender groups.
C. First year cessation
rates
Multipurpose Surveys “Aspects of
daily living”
Breakdowns by age and gender groups.
D. Relapse rates USDHHS (1989) and other studies Breakdowns by age
E. Relative risks of
current and ex-smokers
Cancer Prevention Study II
(NCI 1997)
Breakdowns by age and gender.
III. Policies
A. Taxes Eurostat, and MPOWER Reports
(2008. 2010)
Prices and taxes
B. Clean air laws Past studies, MPOWER Report
(2008, 2010), and labor
force participation rates
Types of laws (worksite, restaurant, and other
places) and their stringency
C. Media & other
educational
campaigns
Tobacco control staff in Italy and
MPOWER Reports (2008. 2010)
Classification based on expenditures per
capita and audience
D. Marketing bans Past studies, and MPOWER Reports
(2008. 2010)
Extent of bans
E. Warning Labels Past studies, and MPOWER Reports
(2008. 2010)
Strictness of labels
F. Cessation Treatment
Policies
Past studies, and MPOWER Reports
(2008. 2010)
Financial reimbursement, quitlines, and brief
interventions
G. Youth access Past studies, and MPOWER Reports
(2008. 2010)
Enforcement checks, penalties, community campaigns,
self-service and vending machine bans
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[8,26-29], but we compared ex-smoker rates and made
adjustments accordingly to calibrate the model. After
calibrating the model, we increased the relapse rate to
75% for ages 30–34, 70% for ages 35–44, 65% for ages
45–54, and 60% for ages 55–64 years.
Smoking-Attributable Deaths
SADs are based on the excess risks of current and
former smokers relative to never smokers. Death rates
by age, gender and smoking status were calculated from
death rates, smoking rates, and relative risks. The num-
ber of current and former smokers at each age was
multiplied by their respective excess risk and summed to
obtain total SADs.
Large scale studies of the relative risk of smoking are
not available for Italy. Since Italy has a similar smoking
history to the United States and is a high incomecountry, we used relative risk estimates from the U.S.
Cancer Prevention Study (CPS) II [28,30,31]. We note
that Doll and Peto [32,33] found similar relative risks in
prospective studies conducted in the UK. For ex-smo-
kers, we allow relative risks to decline at the rate
observed in U.S. studies [34], similar to those found in
the British studies [32,33]. Moreover, CPS II relative risk
estimates were in agreement with those found in Italian
epidemiological studies for several mortality causes [35].
Policy effects
SimSmoke includes a separate policy module for each of
the major policies. Policy effect sizes are in terms of per-
centage reductions applied to smoking prevalence in the
year when the policy was implemented, and, unless
otherwise specified, applied to initiation and cessation
rates in future years. Policies and effect sizes are sum-
marized in Table 2. The effect of implementing a policy
Table 2 Policies, description and effect sizes of the SimSmoke model
Policy Description Potential percentage effect*
Through price elasticity:
Tax Policy Cigarette price index −0.3 ages 15–24
−0.2 ages 25–34
−0.1 ages 35 and above
Clean Air Policies
Worksite total Ban Ban in all areas 6% with variations by age and gender
Worksite ban except
ventilated areas
Smoking restricted to ventilated areas in
all indoor workplaces
4% with variations by age and gender
Worksite ban
limited to common
area
Smoking limited to non ventilated common area 2% with variations by age and gender
Restaurant total ban Ban in all indoor restaurants in all areas 1% effect
Restaurant ban except
separate areas
Ban in all restaurants except in designated areas 0.5% effect
Other places total
ban
Ban in 3 of 4 (malls, retail stores, public transportation
and elevators)
1% effect
Enforcement and
publicity
Government agency is designated to enforce and
publicize the laws
Effects reduced by as much as 50% if 0
enforcement
Mass Media Campaigns
Highly publicized
campaign
Campaign publicized heavily on TV (at least two months
of the year) and at least some other media
3.25% effect (doubled when accompanied
by local programs)
Moderately publicized
campaign
Campaign publicized sporadically on TV and in at least
some other media, and a local program
1.8% effect (doubled when accompanied
by local programs)
Low publicity
campaign
Campaign publicized only sporadically in newspaper,
billboard or some other media.
0.5% effect (doubled when accompanied
by local programs)
Marketing Ban
Comprehensive marketing
ban
Ban is applied television, radio, print, billboard, in-store
displays, sponsorships and free samples
5% reduction in prevalence,
6% reduction in initiation,
3% increase in cessation rates
Total Advertising
Ban
Ban is applied all media television, radio, print, billboard 3% reduction in prevalence,
4% reduction in initiation,
2% increase in cessation rates
Weak advertising
ban
Ban is applied some of television, radio, print, billboard 1% reduction in prevalence and initiation only
Enforcement and
publicity
Government agency is designated to enforce the laws Effects reduced by as much as 50% if 0
enforcement
Warning Labels
Strong Labels are large, bold and graphic 2% reduction in prevalence
2% reduction in initiation
4% increase in cessation rate
Weak Laws cover less than 1/3 of package, not bold or graphic 1% reduction in prevalence & initiation rates,
2% increase in cessation rates
Publicity Health information is well publicized 1% additional effect on
prevalence and initiation rates
Cessation Treatment
Policy
Complete availability and reimbursement of
pharmaco- and behavioral treatments, quitlines,
and brief interventions
4.75% reduction in prevalence, 39% increase
in cessation rate
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Table 2 Policies, description and effect sizes of the SimSmoke model (Continued)
Youth Access Restrictions
Strongly enforced
& publicized
Compliance checks are conducted regularly,
penalties are heavy, and with publicity is
strong, vending machine and self-service bans
30% reduction for age < 16 in prevalence
and initiation only,
20 % reduction for ages 16–17 in prevalence
and initiation only
Well enforced Compliance checks are conducted sporadically,
penalties are potent, and little publicity
15 % reduction for age < 16 in prevalence
and initiation only,
10 % reduction for ages 16–17 in prevalence
and initiation only
Low enforcement Compliance checks are not conducted, penalties
are weak, and no publicity
3 % reduction for age < 16 in prevalence
and initiation only,
2 % reduction for ages 16–17 in prevalence
and initiation only
* Unless otherwise specified, the same percentage effect is applied as a percentage reduction in the prevalence and initiation rate and a percentage increase in
the cessation rate, and is applied to all ages and both genders. The effect sizes are shown relative to the absence of any policy. They are based on literature
reviews, advice of an expert panel and model validation.
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mental effect of a complete work site ban is less when a
country already has a partial worksite ban than if no
smoking ban is implemented). We input data on policy
levels for each year from the baseline year through 2009,
based on the WHO MPOWER reports [1,2] and on data
provided by tobacco control staff in Italy.
Tax policy in SimSmoke uses cigarette prices adjusted
for inflation as the policy input through 2010, which
changes in price are translated into changes in smoking
prevalence through elasticities (i.e., the percent change
in smoking prevalence for a one percent change in
price). The model uses the total cigarette excise tax (in-
cluding ad valorem and specific) to adjust future prices.
Gallus and colleagues [36] obtained price elasticities for
Italy comparable to those in the U.S., with minimal ten-
dencies for smokers to substitute to smuggled cigarettes
and hand rolled cigarettes [37]. The price effects are
assumed to be the same as in U.S. model, where the
elasticity for smoking prevalence is −0.3 for those
through age 24, -0.2 for those aged 25–34, and −0.1 for
those aged 35 and above. Since the vast majority of
tobacco users smoke tobacco, the price was based on
the tobacco price index deflated by the consumer price
index from 1999 through 2009 (stats.oecd.org/index.aspx?
querytype= view&queryname= 221). We examine the ef-
fect of an increase in future tobacco prices by 25% in the
first year (i.e. 2011), an additional 20% the second (relative
to the preceding year), 15% the third, 10% the fourth and
5% the fifth year. This would imply a total 99.3% price in-
crease over the next 5 years, which would be similar to in-
creasing the current ad valorem and specific excise taxes
from its current level by around 20%.
Smoke-free air policy considers smoking restrictions
in: 1) worksites, 2) restaurants and bars, and 3) other
places, with their effect dependent on enforcement
and publicity (based on the level of tobacco controlcampaigns). With strong enforcement and publicity, the
effect of a ban in restaurants is 2%, in pubs and bars is
1%, in worksites is 6%, and in other public places is 1%,
with the full effects dependent on full enforcement,
based on recent reviews [4,38] and studies from Italy
[37,39-41]. Italy now has strong smoke-free air laws.
Dating back to 1975, there were bans on smoking in
many public places, including hospital wards, in all the
school classes, libraries, cinemas and museums, and
in public transport (http://www.salute.gov.it/stiliVita
/paginaInternaMenuStiliVitaFaq.jsp?id=44&menu=stru-
mentieservizi&label=faq), which is designated as a full
ban in other public places. A ban was not implemented
until 2005 for all worksites, bars and restaurants. While
there is an exclusion for ventilated areas, it is very costly
to comply with this regulation. Italy is considered to
have weak worksite laws (ban in government and health
facilities), and no ban in restaurant or pubs and bars
through 2005, and then complete smoke-free air laws
(worksites, bars and restaurants), and other public
places since 2005. Based on information in the MPO-
WER Report [1] for 2007, the enforcement level is set to
8 out of 10.
MPOWER [1] distinguishes enforcement and 4 levels
of direct (advertising and point of sale) and indirect
(sponsorships, branding, or promotional discounts) mar-
keting as: 1) none, 2) minimal (up to 3 direct or 1 indir-
ect ban), 3) moderate (4–6 direct or 1 indirect), and 4)
complete (direct and indirect). With a complete direct
and indirect ban, prevalence is reduced by 5% and initi-
ation by 6%, and cessation is increased by 3% [4,42,43].
Since 1983, there was a ban on direct advertising in
newspapers, radio, and television. In 1991, the ban was
extended to cover most indirect advertising, with some
minor changes in 2004 related to Formula One racing
sponsorship and free distribution practices. According to
the MPOWER Reports, there is a ban on all types of
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having a complete (level 4) marketing ban from the
baseline year to the present. Based on the 2009 MPO-
WER report [2], however, enforcement is 10 for direct
and 3 for indirect, which were averaged to set enforce-
ment to 7 out of 10 for all years.
MPOWER provides 4 levels for health warnings on
cigarette packs: none, minimal (< 30% of the principal
display area), moderate (covering at least 30% of the dis-
play area and includes seven pack warning criteria) and
complete (covers at least 50% of the display area and
includes all seven warning criteria and a ban on deceitful
terms). Based on Levy et al. [4] and more recent studies
[44-46] strong health warnings reduce prevalence by 2%
and initiation by 1%, and increase cessation by 5%.
When warning labels are moderate (low), prevalence is
reduced by 0.75% (0.5%), cessation is increased by 2.5%
(1.0%) and initiation is reduced by 0.5% (0.5%). When
warning labels are moderate or high, a synergy from
publicity through tobacco control campaigns reduces
prevalence by an additional 1% and increases cessation
by an additional 2% if tobacco control funding is high
and half of that amount if it is medium. Health warnings
were minimal in Italy until 2003. Following EU direc-
tives, warnings were increased to cover at least 30% of
both sides of the pack in 2003, but have not included
pictorial images. Thus, we assigned a moderate warning
from 2003 to 2010.
SimSmoke specifies three levels for tobacco control cam-
paigns: 1) low: a national agency and minimal funding or
employees, 2) medium: a national agency plus 10+
employees or per capita expenditures over $0.10 (USD)
per capita, and 3) high: a national agency and expendi-
tures over $0.50 per capita, and incorporates synergies
arising from publicity surrounding other tobacco control
policies. Based on reviews [4,47-49] and several recent
studies [50-53], a well-funded tobacco control campaign
in conjunction with other policies yields an effect size of
6.5%. A low campaign yields an effect size of 1%. Without
other policies in place, the effects are reduced by half.
Anti-tobacco media campaigns have been implemented in
Italy in 2002–2003, 2004, 2005, 2009, and 2010 (http://
www.salute.gov.it/servizio/campagna.jsp). The 2010 media
campaign was a 35 second television spot delivered on
15 days in summer, and cinema and radio spots delivered
from November 15 to December 15, 2010. The MPOWER
Report [1,2] indicates health expenditures of less than $1
USD per person. Because of the sporadic and generally
low level of he campaign, we assign a low intensity media
campaign to Italy since 1999.
A strongly enforced policy restricting the purchase of
cigarettes by youth and with bans on self-service and vend-
ing machines reduces smoking prevalence by those under
the age of 18 by as much as 25% [54]. While retailers havea duty to ensure tobacco products are not sold to anyone
under the age of 16, youth are rarely denied purchase of
cigarettes in Italy [55]. Enforcement is set to a zero level
since the baseline year of the model, with no bans on
vending machines or self-service displays.
Cessation treatment includes four sub-policies. Treat-
ment coverage is based on the places providing cessation
treatments (physician offices, hospitals, community cen-
tres, provider offices and other). With a high-level media
campaign, prevalence is reduced by 2.25%, and the ces-
sation rate is increased by 12% in future years [48,56].
The effect of a quitline also depends on publicity, with
prevalence reduced by 0.5% and cessation increased by
5% in all future years [56]. An index for pharmacother-
apy availability was developed, which was given full
weight if: i) both nicotine replacement therapy (NRT)
and buproprion were available, and ii) NRT is available
in a pharmacy without prescription or general store.
When fully implemented, prevalence is reduced by 1.0%,
and the cessation rate is increased by 6% in all future
years [57,58]. Brief interventions would involve at mini-
mum that health care providers advise and assist in ces-
sation. When fully implemented, prevalence is reduced
by 0.5% in the first year, and the cessation rate is
increased by 10%, based on evidence provided in Levy
et al. [4]. When all sub-policies are implemented (from a
scenario of no policy), smoking prevalence is reduced by
4.75% and the cessation rate is increased by 39.3%.
Since 2003, NRT has been available OTC in pharma-
cies, and was only provided by prescription in previous
years. Buproprion is available with a prescription for all
years. The National Health Service provides no reim-
bursement to smokers for pharmacotherapy or behav-
ioral treatments [59] and there is little use, although
heavy smokers are more frequent compared with other
high income nations [60,61]. Several Smoking Cessation
Services are not adequately funded and their activities
are only periodically implemented [62]. According to the
MPOWER Report [2] and based on the characteristics
described above, financial coverage of treatments is pro-
vided only in some places for primary care facilities, hos-
pitals, and offices of health professionals, and we assume
those values for all years. MPOWER [2] indicates that
there is a quitline, which Italian sources indicate has
been in existence since 1999, but is available for limited
hours and serves only about 0.6-0.7% of smokers [61],
and is considered to be passive. A recent survey found
that only 22% of smokers reported having only received
advice to quit by their general practitioners [63], but an-
other recent survey (PASSI; see http://www.epicentro.iss.
it/passi/english.asp) found that health professionals
delivered smoking cessation counseling to 60% of smo-
kers. We set brief interventions at a level of 30% for all
years.
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As described above, the model estimates the effects over
time for two primary outcomes: smoking prevalence and
SADs. Smoking prevalence is provided for the popula-
tion aged 15 and above, but the model also has the cap-
ability to provide breakdowns by age. Separate results
are provided for males and females and overall. The
model estimates these outcomes for the tracking period,
which is from 1999 to 2010, and projects future out-
comes for 2011 through 2040.
To calibrate the model, we compared trends in the
model over the period from 1999 to 2002 to data
gleaned from ISTAT surveys over the period 1993–2002.
To validate the model, we compared trends from the
model to data from ISTAT for more recent years.
In examining the potential effect of future policies
consistent with the FCTC, we first present the status
quo case, where tobacco control policies are maintained
at their 2010 level. We then consider the effect of vary-
ing levels of tobacco control policies in isolation and
through a comprehensive tobacco control strategy in-
volving all policies being simultaneously implemented inTable 3 SimSmoke Projections: Male smoking prevalence for
POLICY/YEAR 2010
Status Quo Policies 26.8%
Independent Policy Effects
Rolling Price Changes** 26.8%
Complete Smoke Free Air Laws 26.8%
Comprehensive Marketing Ban 26.8%
High Intensity Tobacco Control Campaign 26.8%
Strong Health Warnings 26.8%
Strong Youth Access Enforcement 26.8%
Cessation Treatment Policies 26.8%
Combined Policy Effects
All above 26.8%
% Change in Smoking Prevalence from Status Quo*
Independent Policy Effects
Rolling Price Changes**
Complete Smoke Free Air Laws
Comprehensive Marketing Ban
High Intensity Tobacco Control Campaign
Strong Health Warnings
Strong Youth Access Enforcement
Cessation Treatment Policies
Combined Policy Effects
All above −
* Measured relative to the status quo in the same year, i.e., (SRp,t-SRStatus quo,t)/ S
SRStatus quo,t is the smoking rate in year t under the status quo.
** 25 % change 2010–2011, 20 % change 2011–2012, 15 % change 2012–2013, 10
throughout the remaining projection period.2011. In comparing the effect of policies to the status
quo, we focus on the relative change in smoking preva-
lence, i.e., the change in smoking prevalence from the
status quo in response to the future policy scenario
divided by the status quo smoking prevalence. For SADs,
we calculate lives saved as the difference between the
number of deaths under the new policy and the number
of deaths under the status quo.
For the present study, no ethical approval is required
since only aggregate data obtained from published data-
bases were used
Results
Predictions of smoking prevalence from 2002 to 2010
Smoking prevalence is reported as a percent of the
population aged 15 and above. Between 1999 and 2010,
the model predicts that male smoking rates fell from
31.8% to 26.8%, a 15.7% decline in relative terms, and
that female smoking rates decreased from 16.7% to
14.9%, an 11% decline in relative terms. Comparing to
ISTAT survey data for 1999 and 2003, male smoking
prevalence fell by 4.3% by 2003 compared to 2.6%ages 15 and above, Italy, 2010-2040
2011 2020 2030 2040
26.6% 24.3% 22.2% 20.4%
25.8% 22.0% 19.6% 17.6%
26.5% 24.3% 22.2% 20.4%
26.4% 24.1% 22.0% 20.2%
24.9% 22.6% 20.4% 18.6%
26.5% 24.2% 22.0% 20.2%
26.5% 23.8% 21.2% 19.1%
26.1% 23.2% 20.9% 19.1%
23.4% 18.4% 15.5% 13.3%
−2.7% −9.6% −11.6% −13.5%
−0.2% −0.2% −0.1% −0.1%
−0.7% −0.8% −0.9% −1.0%
−6.1% −7.2% −8.1% −8.7%
−0.2% −0.7% −1.0% −1.2%
−0.4% −2.3% −4.3% −6.2%
−1.9% −4.6% −5.9% −6.5%
12.0% −24.5% −30.3% −34.6%
RStatus quo,t, where SRp,t is the smoking rate in year t with policy p and
% change 2013–2014, 5 % change 2014–2015. Prices kept at 2015 level
Table 4 SimSmoke Projections: Female smoking prevalence for ages 15 and above, Italy, 2010-2040
POLICIES 2010 2011 2020 2030 2040
Status Quo Policies 14.9% 14.8% 14.1% 13.2% 12.0%
Independent Policy Effects
Rolling Price Changes** 14.9% 14.4% 12.8% 11.7% 10.5%
Complete Smoke Free Air Laws 14.9% 14.8% 14.1% 13.2% 12.0%
Comprehensive Marketing Ban 14.9% 14.7% 14.0% 13.1% 11.9%
High Intensity Tobacco Control Campaign 14.9% 13.9% 13.1% 12.1% 11.0%
Strong Health Warnings 14.9% 14.8% 14.0% 13.1% 11.9%
Strong Youth Access Enforcement 14.9% 14.8% 13.8% 12.6% 11.3%
Cessation Treatment Policies 14.9% 14.5% 13.5% 12.4% 11.3%
Combined Policy Effects
All above 14.9% 13.0% 10.8% 9.4% 8.0%
Relative Change in Smoking Prevalence from Status Quo*
Independent Policy Effects
Rolling Price Changes** −2.7% −9.2% −10.9% −12.6%
Complete Smoke Free Air Laws −0.2% −0.2% −0.2% −0.1%
Comprehensive Marketing Ban −0.7% −0.8% −0.9% −0.9%
High Intensity Tobacco Control Campaign −6.2% −7.2% −7.9% −8.5%
Strong Health Warnings −0.2% −0.7% −0.9% −1.1%
Strong Youth Access Enforcement −0.3% −2.2% −4.1% −6.1%
Cessation Treatment Policies −1.9% −4.4% −5.7% −6.4%
Combined Policy Effects
All above −12.0% −23.5% −28.9% −33.2%
* Measured relative to the status quo in the same year, i.e., (SRp,t-SRStatus quo,t)/ SRStatus quo,t, where SRp,t is the smoking rate in year t with policy p and
SRStatus quo,t is the smoking rate in year t under the status quo.
** 25% change 2010–2011, 20% change 2011–2012, 15% change 2012–2013, 10 % change 2013–2014, 5% change 2014–2015. Prices kept at 2015 level
throughout the remaining projection period.
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http://www.biomedcentral.com/1471-2458/12/709predicted by the model, and by 2008 falling by 11.7%
according to surveys compared to 13.9% predicted by
the model. For females, the decrease of 1.8% is greater
than the 0.6% predicted decrease by the model for 2003,
and for 2008 the surveys show a 4.7% actual decrease
compared to a 10.2% decrease predicted by the model.
The survey results for females were highly sensitive to
the year chosen, but the model predicts better relative to
2002. The model also over-predicts reductions at the
younger (<25 years old) and increases at the older (above
45 years old) ages, but is more accurate for the 25–
44 year old age group, the less volatile one.Role of policies implemented in 2010 in reducing future
smoking prevalence and deaths
The estimates of smoking prevalence under the status
quo and under varying policy scenarios are shown in
Table 3 and 4 for males and females respectively. The
total number of projected SADs and lives saved for each
year and the summed numbers over the years 2011–2040 is displayed for the different policies in Table 5.
and 6 for males and females, respectively.
Status quo Scenario
If tobacco control policies remain unchanged from their
2010 levels, as in the status quo scenario, male adult
smoking is projected to decrease in absolute terms by
2.5 percentage points (9.2% in relative terms) from
26.8% to 24.3% over the 10 years between 2010 and
2020, by 4.6 percentage points to 22.2% by 2030, and by
6.4 percentage points (23.8% in relative terms) to 20.4%
over a 30-year projection to 2040. Female smoking
prevalence is projected to decrease by 0.8% in absolute
terms (5.2% in relative terms) in 10 years, by 1.7%
(11.4% in relative terms) in 20 years, by 2.8% (19.1% in
relative trms) over the period 2010–2040.
The estimated number of SADs in 2010 is 60,652 for
males and 18,433 for females. The projected number of
male SADs in Italy is projected to rise through 2020 and
fall below 2010 levels in 2033. Relative to 2010, male
deaths are projected to increase by 4,203 over the 10-
Table 5 Male smoking attributable deaths, SimSmoke Italy, 2010-2040
Policies 2010 2020 2030 2040 Cumulative
Status Quo Policies 60,652 64,855 61,949 54,607 1,854,650
Independent Policy Effects
Rolling Price Changes** 60,652 63,424 58,657 51,042 1,788,696
Complete Smoke Free Air Laws 60,652 64,805 61,837 54,501 1,852,354
Comprehensive Marketing Ban 60,652 64,697 61,598 54,261 1,847,374
High Intensity Tobacco Control Campaign 60,652 63,428 58,619 51,128 1,785,387
Strong Health Warnings 60,652 64,731 61,592 54,138 1,847,242
Strong Youth Access Enforcement 60,652 64,855 61,937 54,493 1,854,008
Cessation Treatment Policies 60,652 63,939 59,387 51,356 1,801,675
Combined Policy Effects
All above 60,652 60,876 52,195 43,617 1,654,086
Absolute Change in Attributable Deaths from Status Quo 2011-2040
Independent Policy Effects
Rolling Price Changes** 1,431 3,292 3,565 65,953
Complete Smoke Free Air Laws 50 112 105 2,296
Comprehensive Marketing Ban 158 351 345 7,276
High Intensity Tobacco Control Campaign 1,427 3,330 3,479 69,263
Strong Health Warnings 124 357 469 7,407
Strong Youth Access Enforcement 0 12 114 641
Cessation Treatment Policies 916 2,562 3,250 52,975
Combined Policies 3,979 9,754 10,990 200,563
** 25% change 2010–2011, 20% change 2011–2012, 15% change 2012–2013, 10 % change 2013–2014, 5% change 2014–2015. Prices kept at 2015 level
throughout the remaining projection period.
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http://www.biomedcentral.com/1471-2458/12/709year period to 2020 and by 1,297 over the 20-year
period. However, male deaths per year decreased by
6,045 over the 30-year period to 2040. Female SADs are
initially 18,433 and projected to increase by 5,957 over a
10-year horizon, by 10,198 over a 20-year period, and by
11,054 over a 30-year period.The effects of individual MPOWER policies
Relative to the status quo scenario (the percentage
change from the status quo), smoking rates are projected
to decline by 2.7% for both males and females by 2011
with an increase in specific taxes which produces a 25%
increase in the retail price. By the end of a 30-year pro-
jection period, the year 2040, the male smoking preva-
lence is projected to decline by about 13.5% and the
female smoking prevalence is predicted to decline by
12.6% from the rolling price increases from 2011 to
2015. Youth smoking prevalence declines at a greater
rate as a result of tax increases than adult prevalence in
the model, and is the primary reason that taxes continue
to reduce adult smoking rates over time. The tax
increases slow the growth of deaths, with 5,357 lives
saved (3,565 male and 1,792 female) in the year 2040.
Summing over years from 2011 (the first year thatdeaths are averted) through 2040, 96,483 deaths are
averted by 2040 with the effects still growing.
Comprehensive smoke-free air laws are already largely
in place, and only require stronger enforcement. They
are predicted to lead to a 0.1% reduction in smoking
prevalence by 2040 relative to the status quo scenario in
2010. Similarly, comprehensive advertising restrictions
are in place, and need better enforcement. The model
predicts a 0.7% immediate reduction in smoking preva-
lence after one year, increasing to about a 1.0% reduction
by 2040.
For a well-funded and publicized campaign that is sus-
tained over time, the model predicts a 6.1% immediate
reduction in smoking prevalence after one year, chan-
ging to an 8.5% reduction by 2040. There is a projected
5,297 fewer smoking-attributable deaths in 2040, cumu-
lating to a total of 101,557 lives saved from 2011 to
2040. The effect of a warning that covers at least 50% of
the principal display area of the pack and includes all
seven pack warning criteria is projected to yield a 0.2%
reduction in smoking prevalence after one year for both
males and females, increasing to about a 1.1% reduction
by 2040. Health warnings are projected to avert 696
fewer SADs in the year 2040 alone, with 10,562 deaths
averted in total by 2040.
Table 6 Female smoking attributable deaths, SimSmoke Italy, 2010-2040
POLICIES 2010 2020 2030 2040 Cumulative
Status Quo Policies 18,433 24,390 28,632 29,488 783,587
Independent Policy Effects
Rolling Price Changes** 18,433 23,816 27,102 27,695 753,057
Complete Smoke Free Air Laws 18,433 24,370 28,578 29,429 782,486
Comprehensive Marketing Ban 18,433 24,326 28,465 29,305 780,155
High Intensity Tobacco Control Campaign 18,433 23,816 27,072 27,670 751,293
Strong Health Warnings 18,433 24,348 28,483 29,260 780,432
Strong Youth Access Enforcement 18,433 24,390 28,629 29,459 783,432
Cessation Treatment Policies 18,433 24,076 27,546 27,876 760,709
Combined Policy Effects
All above 18,433 22,849 24,189 23,890 692,046
Absolute Change in Attributable Deaths from Status Quo 2011-2040
Independent Policy Effects
Rolling Price Changes** 574 1,530 1,792 30,530
Complete Smoke Free Air Laws 21 54 59 1,100
Comprehensive Marketing Ban 65 167 182 3,432
High Intensity Tobacco Control Campaign 575 1,560 1,818 32,294
Strong Health Warnings 42 149 227 3,155
Strong Youth Access Enforcement 0 3 29 155
Cessation Treatment Policies 314 1,085 1,611 22,877
Combined Policies 1,541 4,442 5,598 91,541
** 25% change 2010–2011, 20% change 2011–2012, 15% change 2012–2013, 10% change 2013–2014, 5% change 2014–2015. Prices kept at 2015 level
throughout the remaining projection period.
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a small immediate effect (0.4%) increasing to 6.2% by
2040. Youth access laws are projected to prevent 143
smoking attributable deaths in 2040, with a total of 796
lives saved over the period 2010–2040.
Comprehensive smoking cessation treatment policies
are projected to reduce adult smoking prevalence by 4%
in 2020. These relative reductions increase to 6.5% in
2040. The policies are projected to avert 4,861SADs in
the year 2040, with a total of 75,852 deaths averted in
total by 2040.
The final scenario projects the effect for a combination
of all of the policies above. The model predicts an im-
mediate 12.0% reduction in smoking prevalence in the
first year. By 2040, this smoking prevalence is projected
to decrease by 34.6% in males and 33.2% in females.
Under these same policies, the model projects 16,588
less annual SADs in 2040. The cumulative number of
deaths averted by 2040 is 292,104, of which 200,563 are
males and 91,541 females.
Figure 1 shows the relative contribution of policies as
part of a comprehensive package in 2020. Of the reduc-
tion in male smoking prevalence in 2020 obtained
through a comprehensive set of policies, 38% is due to
progressively doubling retail prices of cigarettes, while29% is from a media campaign, 18% from a comprehen-
sive cessation treatment program, and less than 10% is
due to youth access enforcement. By 2040, the relative
contribution of price decreases slightly along with media
campaigns, while the effect of youth access and health
warning increases. Youth enforcement and taxes tend to
have less immediate effects on mortality than the other
policies, since they have their largest effects on youth.
Discussion
Italy SimSmoke applies population, smoking prevalence,
and policy data for that nation and modified parameter
values to the established SimSmoke model. The model's
credibility is supported by validation in countries with
sufficient data to confirm predicted trends. While Italy
has implemented some tobacco control policies over the
last decade (but not over the last few years [10]), there is
still considerable scope to strengthen tobacco control
policies consistent with the MPOWER policy guidelines.
Using the SimSmoke model, we have presented a short
and long-term projection of the role of various tobacco
control policies in reducing smoking prevalence and,
subsequently, the number of SADs. The smoking preva-
lence can be decreased by as much as 12% in the first
year, and by approximately 34% in 30 years.
Figure 1 Contribution of each of the policies as a percent of the predicted 24.5% reduction in male smoking prevalence in 2020.
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related illnesses, reductions in smoking prevalence have
a relatively small impact on the number of SADs in the
short-term. However, by 2040, more than 18,000 deaths
can be averted in that year alone with the stronger set of
policies. Without effective tobacco control policies,
330,000 lives will be lost due to smoking by the year
2040.
We recommend interpreting these projections in a
conservative manner. The model's results depend on the
reliability of data, and of the estimated parameters and
assumptions used in the models.
The smoking prevalence findings depend first on esti-
mates of the rates of smoking in 1999, and initiation,
cessation and relapse rates. The model over-predicted
the reduction in younger smokers and under predicted
the reduction in older smokers. Future smoking rates
will depend especially on rates of younger smokers, and
are thus subject to uncertainty especially for predictions
further into the future. Reliable data were not available
for relapse rates except for the US, and are based on US
rates [8,26-28]. Data on cessation rates or ex-smokers by
years quit were not available for Italy, so rates from the
Netherlands were used. It will be important to monitor
cessation rates or the distribution of ex-smokers by years
quit in future years to gauge the impact of tobacco con-
trol policies. When more data becomes available on
smoking prevalence, the model can be validated to see
how well it has predicted trends in recent years. In
addition, data on policies in effects should be collected
over time, so that data can be used in updates of the
model and in policy evaluations.
The estimated relative risks for total mortality of smo-
kers are based on CPS-II from the US [8,28,31]. How-
ever, relative risk estimates by cause of death from
Italian epidemiological studies are in agreement with the
CPS-II [35]. Previous SADs estimates for Italian men
[35] using SAMMEC and Peto’s method [64] showed a
peak in SADs in 1985, and then a decrease. Our resultsinstead peak after 2020. Both SAMMEC and Peto’s
methods use relative risks of mortality for about 20
tobacco-related diseases from the CPS II study, and mor-
tality figures for these specific causes. In Italy SimSmoke
we used the relative risks of dying for smokers and
former smokers from the CPS II study, and we applied
these risks to the overall mortality. The differences in the
methods for calculation may explain the differences be-
tween our SADs estimates and those from SAMMEC
and Peto’s methods. At least part of the discrepancies in
SADs is due to the fact that total mortality estimates
used in SimSmoke include causes of death not included
when calculating mortality by cause. Notably, the projec-
tions do not include the additional deaths averted due to
reductions in second hand smoke exposure. In countries
with a high number of male smokers and a low number
of female smokers, a large number of female non-
smokers are exposed to smoke in the home. Recent data
showed that, although the Italian smoking ban intro-
duced in 2005 substantially decreased SHS exposure,
the prevalence of SHS exposure for non-smokers was
10.2% in public places, 15.6% at home, and 17.9% in
transport [65].
The policy effect sizes depend on underlying assump-
tions, estimated parameters of the predicted effect on
initiation and cessation, and assumptions about the
interdependence of policies. Knowledge of the different
effects of each policy varies [4]. For example, many stud-
ies, with relatively consistent results, have been done of
the effects of price. There are also many studies of clean
air laws, with results somewhat less consistent than
those of prices/taxes, but still falling into similar ranges.
Studies on media/tobacco control campaigns and adver-
tising bans provide a broad range of estimates. Informa-
tion on the effect of health warnings and cessation
treatment policies is generally lacking. Better under-
standing of the interactive effects of policies is also
needed. We have made the conservative assumption that
the effects of each policy are a constant proportion of
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indicates that public policies may be synergistic [6]
through their cumulative impact on social norms and
their reinforcing effects on smokers’ motivation to quit.
Furthermore, due to a lack of studies, we were not able
to incorporate how the tobacco industry would respond
or adapt to changes in tobacco control policies via the
development of innovative tobacco marketing and novel
tobacco products, such as smokeless tobacco, and cigars.
In addition, we were not able to explicitly incorporate
network effects through the workplace, peers and
parents.Conclusion
SimSmoke results highlight the relative contribution of
numerous policies to reducing the tobacco health bur-
den. When the tax increases by large percentages, stron-
ger clean air and youth access laws are implemented,
publicized and enforced, a strict advertising and market-
ing law is promulgated and enforced, strong warning
labels are introduced, a high publicity media campaign is
coordinated with the other policies and a strong com-
prehensive cessation treatment program is implemented,
the smoking rate is projected to fall by 34.6% (33.2%) in
males (females) in relative terms and 292,104 total
deaths are averted by the year 2040. Tax/price increases
are also likely to increase government tax revenues [66],
part of which can and should be earmarked to pay for
media campaigns and cessation treatment, and to en-
force smoke-free-air laws and anti-tobacco marketing
policies.
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